- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT00727584
Radiation Therapy in Treating Patients With Metastatic Spinal Cord Compression
SCORAD: A Randomised Feasibility Study of Single Fraction Radiotherapy Compared to Multi-fraction Radiotherapy in Patients With Metastatic Spinal Cord Compression
RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. It is not yet known which radiation therapy regimen is more effective in treating metastatic spinal cord compression.
PURPOSE: This randomized clinical trial is comparing two radiation therapy regimens to see how well they work in treating patients with metastatic spinal cord compression.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
OBJECTIVES:
- To examine whether a phase III randomized study comparing a single-fraction of radiotherapy with multi-fraction radiotherapy is acceptable to clinicians and to patients with metastatic spinal cord compression.
- To determine the feasibility of conducting this study in the United Kingdom.
OUTLINE: This is a multicenter study. Patients are stratified by treatment center and known prognostic factors (ambulatory status at diagnosis, primary tumor type, and extent of disease [spinal metastases only vs spinal and non-bony metastases]). Patients are randomized to 1 of 2 treatment arms.
- Arm I (multi-fraction radiotherapy): Patients undergo 5 fractions of 20 Gy external-beam radiotherapy.
- Arm II (single-fraction radiotherapy): Patients undergo 1 fraction of 8 Gy external beam radiotherapy.
Patients undergo assessment of ambulatory status, quality of life, bladder and bowel function, and acute toxicity via self-reported questionnaires and telephone follow-ups at baseline and weeks 1, 4, 8, and 12.
Tipo di studio
Iscrizione (Anticipato)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
-
Manchester, Regno Unito, M20 6UX
- Christie Hospital
-
-
England
-
Bristol, England, Regno Unito, BS2 8ED
- Bristol Haematology and Oncology centre
-
Northwood, England, Regno Unito, HA6 2RN
- Cancer Research UK and University College London Cancer Trials Centre
-
-
Wales
-
Rhyl, Denbighshire, Wales, Regno Unito, LL 18 5UJ
- Glan Clwyd Hospital
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
DISEASE CHARACTERISTICS:
- Histologically or cytologically confirmed malignant disease
Proven diagnosis of metastatic spinal cord compression on MRI or CT scan
- Single site of compression OR multiple sites that can be treated within a single radiation treatment field
- No patient for whom surgery or chemotherapy treatment is more appropriate
- No multiple myeloma as primary cancer
PATIENT CHARACTERISTICS:
- Life expectancy > 1 month
- Not pregnant
- Willing and able to complete assessment forms
- Able to give informed consent
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
---|---|
Comparatore attivo: Arm I (multi-fraction radiotherapy)
Patients undergo 5 fractions of 20 Gy external-beam radiotherapy.
|
Patients undergo external beam radiotherapy
|
Sperimentale: Arm II (single-fraction radiotherapy)
Patients undergo 1 fraction of 8 Gy external beam radiotherapy.
|
Patients undergo external beam radiotherapy
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
---|
Patient accrual per center over a 12-month period
|
Misure di risultato secondarie
Misura del risultato |
---|
Ambulatory status at 1, 4, 8, and 12 weeks from day 1 of treatment compared to baseline
|
Bladder and bowel function at 1, 4, 8, and 12 weeks from day 1 of treatment compared to baseline
|
Acute side effects using RTOG scales at 1, 4, 8, and 12 weeks from day 1 of treatment
|
Quality of life as measured by the EORTC QLQ-C30 questionnaire at 1, 4, 8, and 12 weeks from day 1 of treatment compared to baseline
|
Further treatment
|
Overall survival at 3, 6, and 12 months
|
Total number of days spent in hospital
|
Preferred place of care
|
Number of patients eligible but not randomized and reasons for non-randomization
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- CDR0000599886
- CRUK-UCL-BRD-07-010
- CRUK-SCORAD
- ISRCTN97555949
- EU-20863
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su radiation therapy
-
Alpha Tau Medical LTD.ReclutamentoCancro della pelle | Neoplasia mucosa della cavità orale | Neoplasia dei tessuti molliItalia
-
Alpha Tau Medical LTD.TerminatoCancro al seno metastatico | Carcinoma al seno | Cancro al seno invasivo | Metastasi a distanza. PatologiaFederazione Russa
-
Abramson Cancer Center at Penn MedicineReclutamentoCancro cervicale | Cancro uterinoStati Uniti
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)Reclutamento
-
Karadeniz Technical UniversityCompletatoEmodialisi | Solitudine | Felicità | Adattamento | Terapia assistita da animali | SintomoTacchino
-
Zealand University HospitalUniversity of Copenhagen; Technical University of Denmark; OptoCeuticsCompletatoMalattia di AlzheimerDanimarca
-
University of AmsterdamAcademic Center for Trauma and Personality; Arkin Mental Health CareIscrizione su invitoDisturbo borderline di personalitàOlanda
-
Medical University of South CarolinaNational Institute on Deafness and Other Communication Disorders (NIDCD)ReclutamentoIctus | Afasia | Afasia non fluenteStati Uniti
-
Rhode Island HospitalSynovation Medical GroupReclutamento
-
Columbia UniversityTerminato